HI homepage

Wearable ultrasound device tracks muscle activity with great accuracy.

The system provides long-term, wireless monitoring of muscle activity and function. Experts are hopeful that it could have utility in multiple healthcare settings. 

differentiating between malignant and vaccine-related lymphadenopathy

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

Using advanced artificial intelligence (AI) platforms to assess imaging results and quantify coronary plaque buildup can help clinicians predict adverse events in patients with suspected coronary artery disease (CAD), according to late-breaking data presented at TCT 2024 in Washington, D.C.

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

The announcement will come as welcome news, as nuclear medicine departments in numerous regions have been grappling with shortages of Mo-99 and Tc-99m.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

AI prostate lesion segmentation algorithm

More detailed estimations of lesion size could give providers greater insight into how to best manage a patient’s treatment plan. 

Around the web

Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.

Imaging and radiology are in a transition right now as more departments and practices are choosing to bring their 3D labs in-house.  

John Simon, MD, CEO of SimonMed Imaging, says imaging has considerably advanced for noninvasive detection of disease and it may be time for it to play a greater role in annual physicals, especially in executive physical exams.